Egyptian International Pharmaceutical Industries Company (EGX: PHAR)
Egypt
· Delayed Price · Currency is EGP 49.28
0.00 (0.00%)
At close: Oct 15, 2024
PHAR Income Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 6,344 | 5,232 | 3,955 | 3,409 | 2,886 | 3,411 | Upgrade
|
| Revenue Growth (YoY) | 42.14% | 32.27% | 16.03% | 18.13% | -15.40% | 21.15% | Upgrade
|
| Cost of Revenue | 3,572 | 2,983 | 2,397 | 1,957 | 1,675 | 2,160 | Upgrade
|
| Gross Profit | 2,772 | 2,248 | 1,558 | 1,452 | 1,211 | 1,252 | Upgrade
|
| Selling, General & Admin | 890.67 | 788.13 | 683.2 | 566.08 | 547.58 | 540.29 | Upgrade
|
| Research & Development | 58.77 | 43.23 | 43.68 | 34.96 | 20.87 | - | Upgrade
|
| Other Operating Expenses | 278.98 | 167.16 | 134.35 | 60.79 | 55.35 | 10.51 | Upgrade
|
| Operating Expenses | 1,324 | 1,038 | 896.23 | 674.83 | 623.8 | 550.8 | Upgrade
|
| Operating Income | 1,448 | 1,211 | 662 | 776.85 | 587.32 | 700.74 | Upgrade
|
| Interest Expense | -584.04 | -388.52 | -195.42 | -136.25 | -83.16 | -57 | Upgrade
|
| Interest & Investment Income | 28.52 | 26.24 | 19.75 | 32.11 | 40.57 | 66.1 | Upgrade
|
| Earnings From Equity Investments | 74.51 | 74.51 | 38.02 | - | 37.18 | 45.83 | Upgrade
|
| Currency Exchange Gain (Loss) | 435.42 | 139.63 | 286.4 | -6.25 | -11.55 | 21.79 | Upgrade
|
| Other Non Operating Income (Expenses) | 22.89 | 1.51 | -20.62 | -24.04 | 13.37 | 51.33 | Upgrade
|
| EBT Excluding Unusual Items | 1,425 | 1,064 | 790.13 | 642.41 | 583.74 | 828.79 | Upgrade
|
| Gain (Loss) on Sale of Assets | 4.71 | 4.69 | 3.7 | 2.78 | 3.8 | 3.14 | Upgrade
|
| Pretax Income | 1,430 | 1,069 | 793.83 | 645.19 | 587.55 | 831.93 | Upgrade
|
| Income Tax Expense | 336.04 | 245.62 | 150.07 | 156.9 | 100.15 | 160.48 | Upgrade
|
| Earnings From Continuing Operations | 1,094 | 823.31 | 643.76 | 488.29 | 487.4 | 671.45 | Upgrade
|
| Minority Interest in Earnings | -1.01 | -0.99 | -0.78 | -0.53 | -0.89 | -0.82 | Upgrade
|
| Net Income | 1,093 | 822.32 | 642.98 | 487.75 | 486.51 | 670.63 | Upgrade
|
| Net Income to Common | 1,093 | 822.32 | 642.98 | 487.75 | 486.51 | 670.63 | Upgrade
|
| Net Income Growth | 27.05% | 27.89% | 31.83% | 0.25% | -27.45% | -4.28% | Upgrade
|
| Shares Outstanding (Basic) | 149 | 149 | 99 | 99 | 98 | 99 | Upgrade
|
| Shares Outstanding (Diluted) | 149 | 149 | 99 | 99 | 98 | 99 | Upgrade
|
| Shares Change (YoY) | - | 50.00% | - | 1.64% | -1.61% | - | Upgrade
|
| EPS (Basic) | 7.34 | 5.53 | 6.48 | 4.92 | 4.99 | 6.76 | Upgrade
|
| EPS (Diluted) | 7.34 | 5.53 | 6.48 | 4.92 | 4.99 | 6.76 | Upgrade
|
| EPS Growth | - | -14.74% | 31.83% | -1.36% | -26.26% | - | Upgrade
|
| Free Cash Flow | -3,640 | -2,200 | -859.77 | -53.27 | -38.7 | 103.18 | Upgrade
|
| Free Cash Flow Per Share | -24.47 | -14.79 | -8.67 | -0.54 | -0.40 | 1.04 | Upgrade
|
| Dividend Per Share | 1.000 | 1.000 | 1.000 | 1.500 | - | - | Upgrade
|
| Dividend Growth | 0% | 0% | -33.33% | - | - | - | Upgrade
|
| Gross Margin | 43.70% | 42.98% | 39.40% | 42.59% | 41.97% | 36.69% | Upgrade
|
| Operating Margin | 22.82% | 23.15% | 16.74% | 22.79% | 20.35% | 20.54% | Upgrade
|
| Profit Margin | 17.22% | 15.72% | 16.26% | 14.31% | 16.86% | 19.66% | Upgrade
|
| Free Cash Flow Margin | -57.38% | -42.05% | -21.74% | -1.56% | -1.34% | 3.03% | Upgrade
|
| EBITDA | 1,546 | 1,314 | 759.39 | 867.73 | 726.89 | 847.53 | Upgrade
|
| EBITDA Margin | 24.37% | 25.11% | 19.20% | 25.46% | 25.19% | 24.85% | Upgrade
|
| D&A For EBITDA | 98.65 | 102.68 | 97.39 | 90.88 | 139.57 | 146.78 | Upgrade
|
| EBIT | 1,448 | 1,211 | 662 | 776.85 | 587.32 | 700.74 | Upgrade
|
| EBIT Margin | 22.82% | 23.14% | 16.74% | 22.79% | 20.35% | 20.54% | Upgrade
|
| Effective Tax Rate | 23.51% | 22.98% | 18.90% | 24.32% | 17.05% | 19.29% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.